Microbial imbalance in Chinese children with diarrhea or constipation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 06 2024
Historique:
received: 15 12 2023
accepted: 26 04 2024
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 12 6 2024
Statut: epublish

Résumé

Diarrhea and constipation are common health concerns in children. Numerous studies have identified strong association between gut microbiota and digestive-related diseases. But little is known about the gut microbiota that simultaneously affects both diarrhea and constipation or their potential regulatory mechanisms. Stool samples from 618 children (66 diarrhea, 138 constipation, 414 healthy controls) aged 0-3 years were collected to investigate gut microbiota changes using 16S rRNA sequencing. Compared with healthy, children with diarrhea exhibited a significant decrease in microbial diversity, while those with constipation showed a marked increase (p < 0.05). Significantly, our results firstly Ruminococcus increased in constipation (p = 0.03) and decreased in diarrhea (p < 0.01) compared to healthy controls. Pathway analysis revealed that Ruminococcus highly involved in the regulation of five common pathways (membrane transport, nervous system, energy metabolism, signal transduction and endocrine system pathways) between diarrhea and constipation, suggesting a potential shared regulatory mechanism. Our finding firstly reveals one core microorganisms that may affect the steady balance of the gut in children with diarrhea or constipation, providing an important reference for potential diagnosis and treatment of constipation and diarrhea.

Identifiants

pubmed: 38866797
doi: 10.1038/s41598-024-60683-6
pii: 10.1038/s41598-024-60683-6
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13516

Informations de copyright

© 2024. The Author(s).

Références

Chu, C., Rotondo-Trivette, S. & Michail, S. Chronic diarrhea. Curr. Probl. Pediatr. Adolesc. Health Care 50, 100841 (2020).
pubmed: 32863166 doi: 10.1016/j.cppeds.2020.100841
George, C. M. et al. Diarrhea prevalence and child growth faltering are associated with subsequent adverse child developmental outcomes in Bangladesh (CHoBI7 Program). Am. J. Trop. Med. Hyg. 106, 233–238 (2022).
doi: 10.4269/ajtmh.21-0767
Manman, L. et al. Lactose-free milk powder can effectively relieve diarrhea symptoms in weaning SD rats and children. Food Sci. Hum. Wellness 2023, 895 (2023).
Liang, G., Gao, H. & Bushman, F. D. The pediatric virome in health and disease. Cell Host Microbe 30, 639–649 (2022).
pubmed: 35550667 doi: 10.1016/j.chom.2022.04.006
Ndungo, E. et al. Dynamics of the gut microbiome in shigella-infected children during the first two years of life. mSystems 7, e0044222 (2022).
pubmed: 36121169 doi: 10.1128/msystems.00442-22
Lunde, C. S. et al. Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nat. Commun. 10, 2816 (2019).
pubmed: 31249291 pmcid: 6597546 doi: 10.1038/s41467-019-10687-y
Fu, R. et al. The mechanism of intestinal flora dysregulation mediated by intestinal bacterial biofilm to induce constipation. Bioengineered 12, 6484–6498 (2021).
pubmed: 34517785 pmcid: 8806846 doi: 10.1080/21655979.2021.1973356
Huang, L., Zhu, Q., Qu, X. & Qin, H. Microbial treatment in chronic constipation. Sci. China Life Sci. 61, 744–752 (2018).
pubmed: 29388040 doi: 10.1007/s11427-017-9220-7
Thomas, S. et al. The Host microbiome regulates and maintains human health: A primer and perspective for non-microbiologists. Cancer Res. 77, 1783–1812 (2017).
pubmed: 28292977 pmcid: 5392374 doi: 10.1158/0008-5472.CAN-16-2929
Camilleri, M. Diagnosis and treatment of irritable bowel syndrome. Jama 325, 865–877 (2021).
pubmed: 33651094 doi: 10.1001/jama.2020.22532
Chen, Y. et al. Predicting the role of the human gut microbiome in constipation using machine-learning methods: A meta-analysis. Microorganisms 9, 2149 (2021).
pubmed: 34683469 pmcid: 8539211 doi: 10.3390/microorganisms9102149
Rouhani, S. et al. Diarrhea as a potential cause and consequence of reduced gut microbial diversity among undernourished children in Peru. Clin. Infect. Dis. 71, 989–999 (2020).
pubmed: 31773127 doi: 10.1093/cid/ciz905
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
pubmed: 21702898 pmcid: 3218848 doi: 10.1186/gb-2011-12-6-r60
Niu, J. et al. Evolution of the gut microbiome in early childhood: A cross-sectional study of Chinese children. Front. Microbiol. 11, 439 (2020).
pubmed: 32346375 pmcid: 7169428 doi: 10.3389/fmicb.2020.00439
Mei, L. et al. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 21, 1 (2021).
doi: 10.1186/s12876-021-01693-w
Wang, J.-K., Yao, S.-K. & Ağagündüz, D. Roles of gut microbiota and metabolites in pathogenesis of functional constipation. Evid.-Based Complement. Alternat. Med.e 2021, 1–12 (2021).
Battaglioli, E. J. et al. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci. Transl. Med. 10, 464 (2018).
doi: 10.1126/scitranslmed.aam7019
Yang, D. et al. Nociceptor neurons direct goblet cells via a CGRP-RAMP1 axis to drive mucus production and gut barrier protection. Cell 185, 4190–4205 (2022).
pubmed: 36243004 pmcid: 9617795 doi: 10.1016/j.cell.2022.09.024
Mekonnen, S. A., Merenstein, D., Fraser, C. M. & Marco, M. L. Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea. Curr. Opin. Biotechnol. 61, 226–234 (2020).
pubmed: 32087535 pmcid: 7096272 doi: 10.1016/j.copbio.2020.01.005
Iddrisu, I. et al. Malnutrition and gut microbiota in children. Nutrients 13, 2727 (2021).
pubmed: 34444887 pmcid: 8401185 doi: 10.3390/nu13082727
Jin, Y. et al. Prediction of postoperative ileus in patients with colorectal cancer by preoperative gut microbiota. Front. Oncol. 10, 526009 (2020).
pubmed: 33324541 pmcid: 7724052 doi: 10.3389/fonc.2020.526009
Fourie, N. H. et al. Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome. Gut Microbes 8, 33–45 (2017).
pubmed: 28059627 pmcid: 5341915 doi: 10.1080/19490976.2016.1273999
Zheng, Y. et al. Microbial profiles of patients with antipsychotic-related constipation treated with electroacupuncture. Front. Med. Lausanne 8, 737713 (2021).
pubmed: 34722577 pmcid: 8551555 doi: 10.3389/fmed.2021.737713
Bae, S., Lyons, C. & Onstad, N. A culture-dependent and metagenomic approach of household drinking water from the source to point of use in a developing country. Water Res. X 2, 100026 (2019).
pubmed: 31194061 pmcid: 6549904 doi: 10.1016/j.wroa.2019.100026
Xu, Y. S. et al. Alteration of the faecal microbiota composition in patients with constipation: Evidence of American Gut Project. Benef. Microbes 13, 427–435 (2022).
pubmed: 36377576 doi: 10.3920/BM2022.0009
Wu, D. et al. Low protein diets supplemented with alpha-ketoglutarate enhance the growth performance, immune response, and intestinal health in common carp (Cyprinus carpio). Front. Immunol. 13, 915657 (2022).
pubmed: 35720284 pmcid: 9200961 doi: 10.3389/fimmu.2022.915657
Liu, L. et al. Antimicrobial resistance and cytotoxicity of Citrobacter spp. in Maanshan Anhui Province, China. Front. Microbiol. 8, 1357 (2017).
pubmed: 28775715 pmcid: 5518651 doi: 10.3389/fmicb.2017.01357
Chen, Y. C. et al. Case-control study of Clostridium innocuum infection, Taiwan. Emerg. Infect. Dis. 28, 599–607 (2022).
pubmed: 35195517 pmcid: 8888209 doi: 10.3201/eid2803.204421
Alimolaei, M. & Afzali, S. Prevalence of Clostridium perfringens toxinotypes in antibiotic-associated diarrheal (AAD) patients in Iranian hospitals; can toxinotype D serve as a possible zoonotic agent for humans?. Acta Trop. 247, 107002 (2023).
pubmed: 37597720 doi: 10.1016/j.actatropica.2023.107002
Berkell, M. et al. Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat. Commun. 12, 2241 (2021).
pubmed: 33854066 pmcid: 8047037 doi: 10.1038/s41467-021-22302-0
Niu, H. et al. Breast milk contains probiotics with anti-infantile diarrhoea effects that may protect infants as they change to solid foods. Environ. Microbiol. 23, 1750–1764 (2021).
pubmed: 33684236 doi: 10.1111/1462-2920.15390
Chen, R. Y. et al. Duodenal microbiota in stunted undernourished children with enteropathy. N. Engl. J. Med. 383, 321–333 (2020).
pubmed: 32706533 pmcid: 7289524 doi: 10.1056/NEJMoa1916004
Collard, J. M. et al. High prevalence of small intestine bacteria overgrowth and asymptomatic carriage of enteric pathogens in stunted children in Antananarivo, Madagascar. PLoS Negl. Trop. Dis. 16, e0009849 (2022).
pubmed: 35533199 pmcid: 9119516 doi: 10.1371/journal.pntd.0009849
Bai, T. et al. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: Protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials 21, 597 (2020).
pubmed: 32605578 pmcid: 7329396 doi: 10.1186/s13063-020-04490-0
El-Soud, N. H., Said, R. N., Mosallam, D. S., Barakat, N. A. & Sabry, M. A. Bifidobacterium lactis in treatment of children with acute diarrhea. A randomized double blind controlled trial. Open Access Maced. J. Med. Sci. 3, 403–407 (2015).
pubmed: 27275258 pmcid: 4877827 doi: 10.3889/oamjms.2015.088
Li, Z. et al. Which probiotic is the most effective for treating acute diarrhea in children? A Bayesian network meta-analysis of randomized controlled trials. Nutrients 13, 12 (2021).
doi: 10.3390/nu13124319
Fu, S. C., Lee, C. H. & Wang, H. Exploring the association of autism spectrum disorders and constipation through analysis of the gut microbiome. Int. J. Environ. Res. Public Health 18, 667 (2021).
pubmed: 33466802 pmcid: 7830459 doi: 10.3390/ijerph18020667
Wei, Y. et al. Protective effects of bifidobacterial strains against toxigenic Clostridium difficile. Front. Microbiol. 9, 888 (2018).
pubmed: 29867801 pmcid: 5952185 doi: 10.3389/fmicb.2018.00888
Yang, B. et al. Protective effect of Bifidobacterium bifidum FSDJN7O5 and Bifidobacterium breve FHNFQ23M3 on diarrhea caused by enterotoxigenic Escherichia coli. Food Funct. 12, 7271–7282 (2021).
pubmed: 34165468 doi: 10.1039/D1FO00504A
Wang, L. et al. Adhesive bifidobacterium induced changes in cecal microbiome alleviated constipation in mice. Front. Microbiol. 10, 1721 (2019).
pubmed: 31456752 pmcid: 6700325 doi: 10.3389/fmicb.2019.01721
Makizaki, Y. et al. Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9–1 is based on correction of gut microbiota dysbiosis. Biosci. Microbiota Food Health 38, 49–53 (2019).
pubmed: 31106107 doi: 10.12938/bmfh.18-020
Xie, L. et al. Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway. J. Transl. Med. 19, 490 (2021).
pubmed: 34852831 pmcid: 8638484 doi: 10.1186/s12967-021-03152-2
McCauley, H. A. Enteroendocrine regulation of nutrient absorption. J. Nutr. 150, 10–21 (2020).
pubmed: 31504661 doi: 10.1093/jn/nxz191
Leta, V. et al. Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence. Brain Behav. Immun. 98, 59–73 (2021).
pubmed: 34364965 doi: 10.1016/j.bbi.2021.07.026
Hagbom, M. et al. The 5-HT(3) receptor affects rotavirus-induced motility. J. Virol. 95, e0075121 (2021).
pubmed: 33980599 doi: 10.1128/JVI.00751-21
Chang-Graham, A. L. et al. Rotavirus induces intercellular calcium waves through ADP signaling. Science 370, 6519 (2020).
doi: 10.1126/science.abc3621
Li, Y. et al. Review: Effect of gut microbiota and its metabolite SCFAs on radiation-induced intestinal injury. Front. Cell Infect. Microbiol. 11, 577236 (2021).
pubmed: 34307184 pmcid: 8300561 doi: 10.3389/fcimb.2021.577236
Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019).
pubmed: 31341288 pmcid: 7015180 doi: 10.1038/s41587-019-0209-9
Estaki, M. et al. QIIME 2 enables comprehensive end-to-end analysis of diverse microbiome data and comparative studies with publicly available data. Curr. Protocols Bioinform. 70, e100 (2020).
doi: 10.1002/cpbi.100
JG, C. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010).
doi: 10.1038/nmeth.f.303
DeSantis, T. Z. et al. Greengenes, a Chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Env. Microbiol. 72, 5069–5072 (2006).
doi: 10.1128/AEM.03006-05
Lozupone, C. & Knight, R. UniFrac: A new phylogenetic method for comparing microbial communities. Appl. Env. Microbiol. 71, 8228–8235 (2005).
doi: 10.1128/AEM.71.12.8228-8235.2005
Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J. & Knight, R. UniFrac: An effective distance metric for microbial community comparison. ISME J. 5, 169–172 (2010).
pubmed: 20827291 pmcid: 3105689 doi: 10.1038/ismej.2010.133
Langille, M. G. I. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814–821 (2013).
pubmed: 23975157 pmcid: 3819121 doi: 10.1038/nbt.2676
Chen, T. et al. The genome sequence archive family: Toward explosive data growth and diverse data types. Genom. Proteom. Bioinform. 19, 578–583 (2021).
doi: 10.1016/j.gpb.2021.08.001
Xue, Y. et al. Database resources of the national genomics data center, china national center for bioinformation in 2022. Nucleic Acids Res. 50, D27–D38 (2022).
doi: 10.1093/nar/gkab951

Auteurs

Jing Ren (J)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Yi Ren (Y)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Yu Mu (Y)

Dr. Cuiyutao Healthcare Co., Ltd., Beijing, China.

Lanying Zhang (L)

Coyote Diagnostics Lab (Beijing) Co., Ltd., Beijing, China.

Binghan Chen (B)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Sisi Li (S)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Qinyi Fang (Q)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Zhiming Zhang (Z)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Kejian Zhang (K)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Sabrina Li (S)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China.

Wei Liu (W)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China. lwbime@163.com.

Yutao Cui (Y)

Dr. Cuiyutao Healthcare Co., Ltd., Beijing, China. yutao.cui@cytclinic.com.

Xu Li (X)

Coyote Bioscience (Beijing) Co., Ltd., Beijing, China. tclxcccc@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH